Claims for Patent: 4,906,755
✉ Email this page to a colleague
Summary for Patent: 4,906,755
Title: | Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds |
Abstract: | The present invention is directed to a group of esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(3H)-ones and related compounds. The compounds are prepared from the appropriate carboxylic acids and alcohols by standard procedures or, where steric factors are significant, a new process which makes use of heavy metal salts of super acids can be used. The compounds involved are useful in the treatment of migraine and similar disorders and in cytotoxic drug-induced vomiting. |
Inventor(s): | Gittos; Maurice W. (Plobsheim, FR) |
Assignee: | Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) |
Application Number: | 07/376,172 |
Patent Claims: |
1. A compound of the formula: ##STR5## wherein the two lines to both A and B indicate a double bond to a single group or two single bonds to two individual groups as
specified; A is (H)(H), .dbd.O, (H)(OH) or .dbd.N--OH; B is (H)(H), (H)(CH.sub.3), (H)(CH.sub.2 NR.sub.3 R.sub.4) or .dbd.CH.sub.2 wherein R.sub.3 and R.sub.4 are C.sub.2-4 alkyl or are combined to give tetramethylene, pentamethylene or --CH.sub.2
CH.sub.2 --O--CH.sub.2 CH.sub.2 --; R.sub.1 is ##STR6## wherein Z is NR.sub.9, O or S; R.sub.5 ; R.sub.6 and R.sub.8 are each hydrogen, halogen, C.sub.1-3 alkyl or C.sub.1-3 alkoxy; R.sub.7 is hydrogen, amino, (C.sub.1-4 alkyl)amino, (C.sub.1-4
alkyl).sub.2 amino, C.sub.1-3 alkoxy or nitro; R.sub.9 is hydrogen, C.sub.1-4 alkyl or phenyl(C.sub.1-2 alkyl); R.sub.10 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, cyano or --CONH.sub.2 ; R.sub.11 is hydrogen, halogen, C.sub.1-4
alkyl or phenyl; the wavy line indicates that the configuration of the oxygen substitutent on the ring can be endo or exo; and the pharmaceutically acceptable acid addition and quaternary ammonium salts of the aforesaid compounds.
2. A compound according to claim 1 which has the formula: ##STR7## wherein the two lines to both A and B indicate a double bond to a single group or two single bonds to two individual groups as specified; A is (H)(H), .dbd.O, (H)(OH) or .dbd.N--OH; B is (H)(H), (H)(CH.sub.3), (H)(CH.sub.2 NR.sub.3 R.sub.4) or .dbd.CH.sub.2 wherein R.sub.3 and R.sub.4 are C.sub.2-4 alkyl or are combined to give tetramethylene, pentamethylene or --CH.sub.2 CH.sub.2 --O--CH.sub.2 CH.sub.2 --; R.sub.1 is ##STR8## wherein Z is NR.sub.9, O or S; R.sub.5, R.sub.6 and R.sub.8 are each hydrogen, halogen, C-.sub.1-3 alkyl or C.sub.1-3 alkoxy; R.sub.7 is hydrogen, amino, (C.sub.1-4 alkyl)amino, (C.sub.1-4 alkyl).sub.2 amino, C.sub.1-3 alkoxy or nitro; R.sub.9 is hydrogen, C.sub.1-4 alkyl or phenyl(C.sub.1-2 alkyl); R.sub.10 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, cyano or --CONH.sub.2 ; R.sub.11 is hydrogen, halogen, C.sub.1-4 alkyl or phenyl; and the pharmaceutically acceptable acid addition and quaternary ammonium salts of the aforesaid compounds. 3. A compound according to claim 1 which has the formula: ##STR9## wherein the two lines to A indicate a double bond to a single group or two single bonds to two individual groups as specified; A is (H)(H), .dbd.O, (H)(OH) or .dbd.N--OH; R.sub.1 is ##STR10## wherein Z is NR.sub.9, O or S; R.sub.5, R.sub.6 and R.sub.8 are each hydrogen, halogen, C.sub.1-3 alkyl or C.sub.1-3 alkoxy; R.sub.7 is hydrogen, amino, (C.sub.1-4 alkyl)amino, (C.sub.1-4 alkyl).sub.2 amino, C.sub.1-3 alkoxy or nitro; R.sub.9 is hydrogen, C.sub.1-4 alkyl or phenyl (C.sub.1-2 alkyl); R.sub.10 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, cyano or --CONH.sub.2 ; R.sub.11 is hydrogen, halogen, C.sub.1-4 alkyl or phenyl, and the pharmaceutically acceptable acid addition and quaternary ammonium salts of the aforesaid compounds. 4. A compound according to claim 1 which has the formula: ##STR11## wherein R.sub.1 is ##STR12## wherein Z is NR.sub.9, O or S; R.sub.5, R.sub.6 and R.sub.8 are each hydrogen, halogen, C.sub.1-3 alkyl or C.sub.1-3 alkoxy; R.sub.7 is hydrogen, amino (C.sub.1-4 alkyl)amino, (C.sub.1-4 alkyl).sub.2 amino, C.sub.1-3 alkoxy or nitro; R.sub.9 is hydrogen, C.sub.1-4 alkyl or phenyl(C.sub.1-2 alkyl); R.sub.10 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, cyano or --CONH.sub.2 ; R.sub.11 is hydrogen, halogen, C.sub.1-4 alkyl or phenyl, and the pharmaceutically acceptable acid addition and quaternary ammonium salts of the aforesaid compounds. 5. A compound according to claim 1 which has the formula: ##STR13## wherein R.sub.1 is ##STR14## wherein Z is NR.sub.9, O or S; R.sub.5, R.sub.6 and R.sub.8 are each hydrogen, halogen, C.sub.1-3 alkyl or C.sub.1-3 alkoxy; R.sub.7 is hydrogen, amino, (C.sub.1-4 alkyl)amino, (C.sub.1-4 alkyl).sub.2 amino, C.sub.1-3 alkoxy or nitro; R.sub.9 is hydrogen, C.sub.1-4 alkyl or phenyl(C.sub.1-2 alkyl(l R.sub.10 is hydrogen, halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, cyano or --CONH.sub.2, and the pharmaceutically acceptable acid addition and quaternary ammonium salts of the aforesaid compounds. 6. A compound according to claim 1 which is endo-8-(3,5-dimethylbenzoyloxy) hexahydro-2,6-methano-2H-quinolizin-3(4H)-one. 7. A compound according to claim 1 which is endohexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one . 8. A compound according to claim 1 which is endo-hexahydro-8-(1-methyl-3-indazolylcarbonyloxy)-2,6-methano-2H-quinoliz in-3(4H)-one. 9. Endo-Hexahydro-8hydroxy-2,6-methano-2H-quinolizin-3(4H)-one. 10. A compound according to claim 1 which is exo-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one . |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.